Literature DB >> 927037

Ursodeoxycholate - in vitro cholesterol solubility and changes of composition of human gallbladder-bile after oral treatment.

H Igimi, N Tamesue, Y Ikejiri, H Shimura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 927037     DOI: 10.1016/0024-3205(77)90021-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Calcification of radiolucent gall stone during treatment with ursodeoxycholic acid.

Authors:  M C Bateson; I A Bouchier; D B Trash; D P Maudgal; T C Northfield
Journal:  Br Med J (Clin Res Ed)       Date:  1981-09-05

Review 2.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

3.  Liquid crystal formation in ursodeoxycholate-rich human gallbladder bile.

Authors:  H Igimi; S Asakawa; D Watanabe; H Shimura
Journal:  Gastroenterol Jpn       Date:  1983-04

4.  Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile.

Authors:  S Mizuno; S Tazuma; G Kajiyama
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

5.  Cholesterol (thermodynamic) activity determinations in bile salt-lecithin-cholesterol systems and cholesterol-rich liquid crystalline mesophase formation.

Authors:  U K Jain; W I Higuchi; C L Liu; P H Lee; N A Mazer
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

Review 6.  Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

Review 7.  The effect of drugs on bile flow and composition. An overview.

Authors:  L Okolicsanyi; F Lirussi; M Strazzabosco; R M Jemmolo; R Orlando; G Nassuato; M Muraca; G Crepaldi
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.